Price Alert

Haemonetics Corporation (HAE)

NYSE: HAE · Real-Time Price · USD

53.11

0.78 (1.49%)

At close: Aug 15, 2025, 10:00 AM

Haemonetics Income Statement

Financials in USD. Fiscal year is May - April.

Fiscal Year	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 28, 2025	Mar 29, 2025	Dec 28, 2024	Sep 28, 2024	Jun 29, 2024	Mar 30, 2024	Dec 30, 2023	Sep 30, 2023	Jul 1, 2023	Apr 1, 2023	Dec 31, 2022	Oct 1, 2022	Jul 2, 2022	Apr 2, 2022	Jan 1, 2022	Oct 2, 2021	Jul 3, 2021	Apr 3, 2021	Dec 26, 2020	Sep 26, 2020	Jun 27, 2020
Revenue	321.39M	330.6M	348.54M	345.51M	336.17M	343.29M	336.25M	318.18M	311.33M	304.42M	305.3M	297.49M	261.46M	265M	259.77M	239.9M	228.53M	225.03M	240.37M	209.49M	195.58M
Cost of Revenue	140.93M	137.55M	155M	158.07M	161.25M	171.69M	158.38M	147.67M	144.07M	148.17M	146.59M	139.61M	119.19M	128.69M	121.2M	117.36M	120.44M	143.22M	120.11M	103.74M	105.55M
Gross Profit	180.47M	193.05M	193.55M	187.44M	174.92M	171.6M	177.87M	170.51M	167.26M	156.25M	158.71M	157.88M	142.26M	136.31M	138.56M	122.54M	108.08M	81.81M	120.26M	105.74M	90.03M
Operating Income	55.14M	71.33M	59.03M	51.7M	39.76M	51.16M	45.98M	35.3M	53.66M	35.26M	43.28M	46.73M	30.77M	19.2M	35.65M	24.51M	1.39M	-21.18M	40.42M	58.78M	11.71M
Interest Income	n/a	n/a	n/a	n/a	6.96M	n/a	n/a	n/a	3.38M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	45.17M	70.74M	49.92M	44.7M	46.71M	23.41M	44.03M	32.83M	51.59M	32.63M	42.22M	41.06M	25.49M	15.33M	31.39M	19.92M	-3.01M	-27.4M	37.37M	54.96M	7.98M
Net Income	34.03M	57.98M	37.49M	33.83M	38.37M	20.37M	31.24M	24.91M	41.04M	29.38M	32.94M	33.2M	19.88M	9.74M	23.23M	14.86M	-4.45M	-11.04M	31.88M	48.1M	10.53M
Selling & General & Admin	109.75M	115.36M	106.46M	106.95M	107.98M	106.44M	111.71M	104.9M	93.48M	97.38M	94.66M	92.41M	92.23M	91.84M	80.73M	75.78M	91.22M	83.71M	73.45M	71.7M	69.54M
Research & Development	15.58M	15.91M	15.83M	16.53M	14.45M	13.99M	13.27M	12.66M	12.65M	15.64M	12.69M	10.9M	10.9M	13.21M	10.04M	10.85M	12.7M	10.84M	7.5M	6.76M	7.75M
Other Expenses	n/a	n/a	12.23M	12.26M	12.47M	n/a	6.91M	17.64M	7.47M	7.97M	8.08M	8.22M	8.37M	11.48M	12.15M	11.4M	12.38M	8.63M	n/a	n/a	n/a
Operating Expenses	125.33M	131.27M	134.52M	135.74M	122.44M	120.44M	131.89M	124.79M	113.61M	120.99M	115.43M	111.53M	111.5M	116.53M	102.91M	98.03M	116.3M	103.18M	80.95M	78.46M	77.29M
Interest Expense	4.07M	598K	9.11M	6.99M	6.96M	6.53M	1.95M	2.47M	2.07M	2.63M	1.05M	5.67M	5.27M	3.87M	4.26M	4.59M	4.4M	6.22M	3.05M	3.83M	3.73M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	7.1M	n/a	n/a	n/a	7.2M	n/a	n/a	n/a	4.4M	n/a	n/a	n/a	2.7M	n/a	n/a	n/a
Cost & Expenses	266.26M	268.82M	289.51M	293.81M	291.79M	292.13M	290.27M	272.46M	257.67M	120.99M	262.02M	251.13M	230.69M	245.23M	224.12M	215.39M	236.74M	246.4M	201.06M	182.2M	182.83M
Income Tax Expense	11.14M	12.76M	12.42M	10.87M	8.34M	3.05M	12.79M	7.92M	10.55M	3.24M	9.28M	7.86M	5.62M	5.59M	8.16M	5.07M	1.45M	-16.36M	5.49M	6.86M	-2.55M
Shares Outstanding (Basic)	48.11M	49.19M	50.29M	50.9M	50.94M	50.79M	50.77M	50.73M	50.54M	50.45M	50.51M	50.95M	51.22M	51.12M	51.09M	51.04M	49.49M	50.21M	50.79M	50.7M	50.42M
Shares Outstanding (Diluted)	48.35M	49.48M	50.64M	51.24M	51.56M	51.41M	51.45M	51.4M	51.34M	51.22M	51.22M	51.56M	51.68M	51.35M	51.34M	51.46M	50.94M	50.85M	51.36M	51.09M	51.25M
EPS (Basic)	0.71	1.17	0.75	0.66	0.75	0.40	0.62	0.49	0.81	0.58	0.65	0.65	0.39	0.19	0.45	0.29	-0.09	-0.22	0.63	0.95	0.21
EPS (Diluted)	0.70	1.17	0.74	0.66	0.74	0.40	0.61	0.48	0.80	0.57	0.64	0.64	0.38	0.19	0.45	0.29	-0.09	-0.22	0.62	0.94	0.21
EBITDA	78M	99.54M	88.05M	80.91M	68.89M	78.8M	69.51M	35.3M	76.69M	59.11M	66.85M	70.17M	53.21M	44.01M	59.94M	48.04M	26.42M	735K	61.2M	79.66M	32.44M
EBIT	49.24M	71.33M	59.03M	51.7M	39.76M	29.94M	45.98M	35.3M	53.66M	35.26M	43.28M	46.73M	30.77M	19.2M	35.65M	24.51M	1.39M	-21.18M	40.42M	58.78M	11.71M
Depreciation & Amortization	28.76M	28.21M	29.02M	29.22M	29.14M	27.64M	23.53M	7.22M	23.03M	23.85M	23.57M	23.44M	22.45M	24.81M	24.37M	23.53M	25.03M	21.91M	20.77M	20.88M	20.72M